Acquired angioedema associated with hereditary angioedema due to C1 inhibitor deficiency

Journal of Investigational Allergology and Clinical Immunology

Volumn 18, Issue 2, 2008, Pages 126-130

  Guilarte, Mar ^a,b   Luengo, O ^a   Nogueiras, C ^a   Labrador Horrillo, M ^a   Munoz E ^a   Lopez A ^b   Cardona, V ^a  

^a Department of Paediatrics   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acquired angioedema; C1 inhibitor deficiency; C1q; Hereditary angioedema

Indexed keywords

CHLORAMBUCIL; COMPLEMENT COMPONENT C1S INHIBITOR; PREDNISONE; STANOZOLOL; TRANEXAMIC ACID;

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPLEMENT DEFICIENCY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG DOSE INCREASE; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LABORATORY TEST; LYMPHOCYTE COUNT; NODULAR LYMPHOMATOSIS; PERIPHERAL EDEMA; PHYSICAL EXAMINATION;

ANGIOEDEMA; ANGIOEDEMA, HEREDITARY; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMPLEMENT ACTIVATION; COMPLEMENT C1; COMPLEMENT C1 INACTIVATOR PROTEINS; FEMALE; HUMANS; LYMPHOCYTE COUNT; LYMPHOMA, FOLLICULAR; MIDDLE AGED; PEDIGREE; STANOZOLOL;

EID: 45749134192     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C,Farkas H, Fay K, Fekete B, Fischer B, Fontana L, Fust G, Giacomelli R, Groner A,Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmar L, Kaposi PN, Karadi I,Kitzinger A, Kollar T, Kreuz W, Lakatos P, Longhurst HJ, Lopez-Trascasa M, Martinez-Saguer I, Monnier N, Nagy I, Nemeth E, Nielsen EW, Nuijens JH, O'gradyC, Pappalardo E, Penna V, Perricone C, Perricone R, Rauch U, Roche O, Rusicke E, Spath PJ, Szendei G, Takacs E, Tordai A, Truedsson L, Varga L, Visy B, Williams K, Zanichelli A, Zingale L. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114(3 Suppl):S51-131.
2. Roche O, Blanch A, Caballero T, Sastre N, Callejo D, López-Tracasa M. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol. 2005;94:498-503.
3. Caballero MT, Lopez-Serrano MC. Angioedema por déficit de C1 inhibidor. Alergol Immunol Clin. 2000;15 (Extraordinario Num 2): 148-59.
4. Cicardi M, Zingale LC, Pappalardo E, Folcioni A, Agostoni A. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore). 2003;82:274-81
5. Cicardi M, Veleta A, Colombo M, Gioffré D, Cugno M, Agostoni A. Relevance of lymphoproliferative disorders and anti-C1 inhibitor autoantibodies in acquired angioedema. Clin Exp Immunol. 1996;106:475-80.
6. Melamed J, Alper CA, Cicardi M, Rosen FS. The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiency. J Allergy Clin Immunol. 1986;77:322-6.
7. Alsenz J, Lambris JD, Bork K, Loos M. Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies. J Clin Invest. 1989;83:1794-9.
8. Jackson J, Sim RB, Whaley K, Feighery C. Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema. J Clin Invest. 1989 Feb;83:698-707.
9. Bouillet-Claveyrolas L, Ponard D, Drouet C, Massot C.Clinical and biological distinctions between type I and type II acquired angioedema. Am J Med. 2003;115: 420-1.
10. Markovic SN, Inwards DJ, Frigas EA, Phyliky RP. Acquired C1 esterase inhibitor deficiency. Ann Intern Med. 2000;132:144-50.
11. Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W, Zingale L, Varga L, Martinez-Saguer I, Aygoren-Pursun E, Binkley K, Zuraw B, Davis A 3rd, Hebert J,Ritchie B, Burnham J, Castaldo A, Menendez A, Nagy I, Harmat G, Bucher C,Lacuesta G, Issekutz A, Warrington R, Yang W, Dean J, Kanani A, Stark D, McCusker C, Wagner E, Rivard GE, Leith E, Tsai E, MacSween M, Lyanga J, Serushago B, Leznoff A, Waserman S, de Serres J. Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. J Allergy Clin Immunol. 2004;114:629-37.
12. Cugno M, Cicardi M, Agostoni A. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol. 1994;93:870-6.
13. Cicardi M, Bisiani G, Cugno M, Spath P, Agostoni A. Autoimmune C1 inhibitor deficiency: report of eight patients. Am J Med. 1993;95:169-75.
14. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-95.
15. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33-64.